Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of outpatient adherence to recommendations for monitoring of patients hospitalized for heart failure.
Corrao G, Rea F, Iommi M, Lallo A, Fantaci G, Di Martino M, Davoli M, Leoni O, Pompili M, Scondotto S, De Luca G, Carle F, Lorusso S, Giordani C, Di Lenarda A, Maggioni AP; Monitoring and Assessing care Pathways (MAP)' working group of the Italian Ministry of Health. Corrao G, et al. Among authors: davoli m. ESC Heart Fail. 2024 May 9. doi: 10.1002/ehf2.14779. Online ahead of print. ESC Heart Fail. 2024. PMID: 38725148 Free article.
Regional and national antimicrobial stewardship activities: a survey from the Joint Programming Initiative on Antimicrobial Resistance-Primary Care Antibiotic Audit and Feedback Network (JPIAMR-PAAN).
Michalsen BO, Xu AXT, Alderson SL, Bjerrum L, Brehaut J, Bucher HC, Clarkson J, Duncan E, Grimshaw J, Gunnarsson R, Høye S, Ivers N, Lecky DM, Lindbæk M, Llor C, Lundgren PT, O'connor D, Pulcini C, Ramsay C, Sundvall PD, Verheij T, Schwartz KL; JPIAMR-PAAN. Michalsen BO, et al. JAC Antimicrob Resist. 2023 Apr 24;5(2):dlad048. doi: 10.1093/jacamr/dlad048. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 38659427 Free PMC article.
Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016-2020.
Kirchmayer U, Marino C, Feriozzi S, Massimetti C, Manzuoli M, Angelici L, Bargagli AM, Cascini S, Addis A, Davoli M, Agabiti N. Kirchmayer U, et al. Among authors: davoli m. BMC Nephrol. 2024 Mar 16;25(1):98. doi: 10.1186/s12882-024-03539-5. BMC Nephrol. 2024. PMID: 38493085 Free PMC article.
[How to optimize Audit&Feedback: experience from the EASY-NET programme].
Acampora A, Angioletti C, D'Agostino M, Deroma L, Tullio A, Pagano E, Ciccone G, Marchesini G, Grilli R, Bonomi A, Marenzi G, Giusti A, Venturella R, Ciurleo R, Bramanti P, Davoli M, Agabiti N. Acampora A, et al. Among authors: davoli m. Epidemiol Prev. 2023 Nov-Dec;47(6):379-390. doi: 10.19191/EP23.6.A664.074. Epidemiol Prev. 2023. PMID: 38314546 Free article. Italian.
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.
Finocchietti M, Marino ML, Rosa AC, Bellini A, Masiero L, Cardillo M, Massari M, Spila Alegiani S, Pierobon S, Ferroni E, Zanforlini M, Leoni O, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT Study Group. Finocchietti M, et al. Among authors: davoli m. Drug Des Devel Ther. 2024 Jan 12;18:53-69. doi: 10.2147/DDDT.S431121. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38229916 Free PMC article.
Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.
Bellini A, Finocchietti M, Rosa AC, Nordio M, Ferroni E, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Pierobon S, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Bellini A, et al. Among authors: davoli m. PLoS One. 2024 Jan 2;19(1):e0295205. doi: 10.1371/journal.pone.0295205. eCollection 2024. PLoS One. 2024. PMID: 38165971 Free PMC article.
471 results